Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)

Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)

CD BioGlyco is a leading global biology company, and we are committed to providing the most comprehensive and high-quality one-stop customized services in the field of cancer glucose metabolism.

What We Do

Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM) is a dedicated cancer glucose metabolism profiling platform. Based on multi-omics technologies such as genomics, proteomics, and metabolomics, it provides quantitative analysis and functional analysis of glucose metabolites at the cell, tissue, and animal levels during the whole process of cancer progression, metabolic enzyme expression and activity detection, and glucose metabolism, flux analysis. We expect to provide a full range of services for cancer glucose metabolism research and promote the application of cancer glucose metabolism research in the fields of cancer prevention, diagnosis and treatment.

Our Advantages

  • Comprehensive service

We provide comprehensive services covering genomics, metabolomics, proteomics, and metabolic fluxomics.

  • Unique platform

A multi-omics platform dedicated to providing cancer glucose metabolism research services.

  • Personalized service

We provide personalized service based on the customers' research priorities.

The Core of Our Platform

Leveraging four unique cancer omics technology to change the paradigm of cancer glucose metabolism research.

Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)

Guide cancer research with multi-omics data on cancer glucose metabolism, and find the intervention method of glucose metabolism to cure cancer.

Our Technologies

If you are interested in our services, please contact us for more detailed information.

This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.